Results 201 to 210 of about 15,426 (247)
Some of the next articles are maybe not open access.

Long‐term follow‐up of allergic bronchopulmonary aspergillosis treated with glucocorticoids: A study of 182 subjects

Mycoses (Berlin), 2023
The long‐term outcomes of allergic bronchopulmonary aspergillosis (ABPA) are poorly characterised.
R. Agarwal   +8 more
semanticscholar   +1 more source

Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis

Seminars in Respiratory and Critical Care Medicine, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to airway colonization by Aspergillus fumigatus in patients with asthma and cystic fibrosis. The pathophysiology of ABPA involves a complex interplay between the fungus
R. Agarwal, V. Muthu, I. Sehgal
semanticscholar   +1 more source

Allergic bronchopulmonary aspergillosis in India

Clinical and Experimental Allergy, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune‐mediated reactions mounted against Aspergillus fumigatus. The disorder most commonly complicates the course of patients with asthma and cystic fibrosis.
R. Agarwal   +4 more
semanticscholar   +1 more source

A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma

European Respiratory Journal, 2021
Background Whether a combination of glucocorticoid and antifungal triazole is superior to glucocorticoid alone in reducing exacerbations in patients with allergic bronchopulmonary aspergillosis (ABPA) remains unknown. We aimed to compare the efficacy and
R. Agarwal   +7 more
semanticscholar   +1 more source

Comparative diagnostic accuracy of immunoprecipitation versus immunoassay methods for detecting Aspergillus fumigatus‐specific IgG in allergic bronchopulmonary aspergillosis: A systematic review and meta‐analysis

Mycoses (Berlin), 2022
The diagnostic accuracy of immunoassays versus immunoprecipitation methods for detecting A.fumigatus‐specific IgG in patients with allergic bronchopulmonary aspergillosis (ABPA) complicating asthma remains unclear.
I. Sehgal   +5 more
semanticscholar   +1 more source

A Randomized Trial of Itraconazole vs Prednisolone in Acute‐Stage Allergic Bronchopulmonary Aspergillosis Complicating Asthma

Chest, 2018
R. Agarwal   +7 more
semanticscholar   +3 more sources

Estimating the minimal important difference in FEV1 for patients with allergic bronchopulmonary aspergillosis

European Respiratory Journal, 2022
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic lung disorder caused by immunological reactions targeted against Aspergillus fumigatus colonising the airways of asthma and cystic fibrosis patients [1].
R. Agarwal   +5 more
semanticscholar   +1 more source

Allergic Bronchopulmonary Aspergillosis

Chest, 1984
Since 1968 the number of reported cases of allergic bronchopulmonary aspergillosis in the United States has risen secondary to increased awareness by physicians and to improved diagnostic criteria for identifying the disease. The eight diagnostic criteria, the five clinical stages of the disease, the common radiographic changes, the pathologic findings,
A J, Ricketti   +3 more
openaire   +6 more sources

Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly

Mycoses (Berlin), 2021
The prevalence and outcomes of allergic bronchopulmonary aspergillosis (ABPA) in the elderly remain unknown.
V. Muthu   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy